Beck Bode, LLC Inovio Pharmaceuticals, Inc. Transaction History

Beck Bode, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$0.79 - $1.91 $11,053 - $26,724	13,992 Added 51.39%	41,218 $33,000
Q4 2022 Feb 07, 2023	BUY	$1.41 - $2.5 $38,388 - $68,065	27,226 New	27,226 $42,000
Q3 2021 Oct 22, 2021	SELL	$7.16 - $9.69 $20,821 - $28,178	-2,908 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$6.23 - $10.03 $18,116 - $29,167	2,908 New	2,908 $27,000
Q1 2021 May 10, 2021	SELL	$8.81 - $16.96 $16,809 - $32,359	-1,908 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$9.57 - $27.05 $18,259 - $51,611	1,908 New	1,908 $22,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $544M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.